Join a Legacy of Innovation 125 Years and Counting! Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders. Summary As a core member of the Global Oncology Medical Affairs (GOMA) Leadership Team, this role is accountable for shaping the GOMA CDx vision and objectives as well as the holistic Companion Diagnostics Medical Affairs strategies for molecules and therapeutic areas where DS operates in oncology. This role will also oversee the execution of the global medical affairs activities related biomarkers and CDx, ensuring alignment with pipeline priorities and precision medicine goals. This role and their team will partner closely across several functions within Global Oncology Medical Affairs, Regional Medical Affairs, Precision Medicine, Clinical Development, RWE/HEOR, Discovery and Business Development as well as Oncology Business Unit Leadership Team.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Executive
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees